No abstract available.

OBJECTIVE: To compare surgical outcomes of patients with myoma after robot-assisted laparoscopic myomectomy and laparoscopic myomectomy. METHODS: Retrospective chart review of 15 robot-assisted laparoscopic myomectomy (RLM) patients and 30 laparoscopic myomectomy (LM) patients at Jeju National University Hospital in Jeju between July 2009 and July 2012. Clinical features and surgical outcomes were compared. RESULTS: Surgical time was longer among RLM patinets (185.7 min vs 114.4 min). Patients undergoing robot-assisted myomectomy had a bigger size of the largest myoma, and bigger average size of the myomas. When adjusted for myoma size and number, no significant differences were noted between robotic (RLM: 24.5 min/cm) vs laparoscopic (LM: 21.5 min/cm) groups for mean operating time/total diameter. Blood loss (1.7 g/dl vs 1.95 g/dl), transfusion (0% vs 6.6%) were both no significant differences between the robotic and laparoscopic groups. CONCLUSION: When adjusted for myoma size and number, short-term outcomes were similar after robotic and laparoscopic myomectomy. Robot-assisted myomectomy is considered reliable procedure.
Humans ; Laparoscopy ; Myoma ; Operative Time ; Retrospective Studies

No abstract available.
Lung* ; Thorax*

BACKGROUND: This study investigated the current status of communication about death and confidence levels concerning death-related issues among Korean adults.METHODS: A survey was conducted to ascertain the frequency of death related communication, factors promoting and impeding such communication, and confidence levels concerning death-related issues. Data of 112 participants who completed the survey were analyzed using descriptive statistics, a chi square test, and multiple logistic regression.RESULTS: More than half of the participants (52.7%–84.0%) appeared to have infrequent (never/at least one) conversations about death or death-related issues. Owing to socio-cultural aspects, death-related communication was considered a taboo or an unpleasant topic of conversation. Additionally, indifference toward death inhibited people from communicating; however, personal experiences of death or morbidity and favorable social contexts promoted communication. Overall, the confidence levels concerning death-related issues was low. Only 17.9%–32.2% of the participants were confident/very confident about their preferences concerning death-related issues. The more people talked about death, the more likely they were to develop a confident attitude toward death-related issues (odds ratio, 3.45; 95% confidence interval, 1.37–8.69).CONCLUSION: This study confirmed that communication about death is being withheld among Koreans, and this could possibly lower their level of confidence regarding death-related issues. To achieve death with dignity, a ‘death culture’ needs to be promoted alongside legislation and infrastructure.
Adult ; Advance Care Planning ; Attitude to Death ; Humans ; Logistic Models ; Personal Autonomy ; Right to Die ; Taboo ; Terminal Care

Malignant mixed mullerian tumor (MMMT) arising from female internal genitalia is rare with the uterine corpus being the most prevalently affected site. It is even more rare when it occurs on both uterus and ovary at the same time. We describe a case of synchronized occurrence of MMMT on ovary and uterine adenosarcoma with review of literature.
Adenosarcoma ; Female ; Genitalia ; Humans ; Ovary ; Uterine Neoplasms ; Uterus

Hot flush (hot flush or facial flush) is the most frequent symptom experienced by women of peri-menopausal age. It may appear on women or even men after surgery or chemotherapy. Hot flush is one of the biggest reason for women to undergo hormone replacement therapy (HRT). It also crucially affects various aspects of life quality such as occupation, social life, daily routine and health awareness. The most effective and fundamental remedy for hot flush is HRT. However, a few women is not responsive to HRT and investigation to elucidate other causes of hot flush is warranted, especially in elderly. The contraindications such as breast cancer mandates other modality of treatment. Variety of treatment for hot flush other than HRT will be discussed herein.
Aged ; Breast Neoplasms ; Drug Therapy ; Female ; Hormone Replacement Therapy ; Humans ; Male ; Occupations ; Quality of Life

Carcinosarcomas of the uterine cervix are extremely rare. Cervical carcinosarcoma can be characterized by having two different origins: the Mullerian ducts and the mesonephric duct remnants. A 53-year-old Korean woman was admitted to the hospital because of pelvic mass detected on computed tomography scan done at private clinic. A Radical hysterectomy with bilateral salpingooophorectomy and pelvic lymphadenectomy was carried out upon a diagnosis of stage IB2 cervical sarcoma. Immunohistochemically, the epithelial component was positive for pancytokeratin and estrogen receptor, but negative for CD 10 and carletinin. The mesenchymal component was positive for vimentin. The histopathologic diagnosis was a carcinosarcoma of the uterine cervix arising from Mullerian ducts. She underwent chemotherapy. She developed systemic recurrence seven months after operation and died of disease. The origin of cervical carcinosarcoma needs to be verified and immunohistochemical studies using mesonephric marker (CD 10, carletinin, and estrogen receptor) is helpful.
Breast Neoplasms ; Carcinosarcoma* ; Cervix Uteri* ; Diagnosis ; Drug Therapy ; Estrogens ; Female ; Humans ; Hysterectomy ; Lymph Node Excision ; Middle Aged ; Mullerian Ducts* ; Recurrence ; Sarcoma ; Vimentin ; Wolffian Ducts

OBJECTIVE: Red cell distribution width (RDW) is associated with mortality in patients with community- acquired pneumonia (CAP). However, little is known about the effect of changes in RDW during treatment on mortality. Thus, the objective of this study was to evaluate the association between RDW changes and mortality in hospitalized patients with CAP. METHODS: Retrospective analyses were performed using medical records of patients hospitalized for CAP from April 2008 to February 2014. The abstracted laboratory values included RDW (from days one to four), clinical variables, and pneumonia severity index (PSI) scores. The ΔRDW(n-1) was defined as the change in RDW calculated as: (RDW(day1)-RDW(day-n))/RDW(day1)×100 (%), where ‘day n’ refers to hospital day. RESULTS: During the study period, a total of 1,069 patients were hospitalized for CAP. The 30-day mortality was 100/1,069 (9.4%). The median RDW at baseline was 14.1% (range, 11.1 to 30.2) and differed significantly between survivors and non-survivors (P<0.05). There were 470 patients with available serial RDW data (30-day mortality 58/470 [12.3%]). Of those, age, PSI score, blood urea nitrogen level, total protein concentration, albumin level, RDW at day 1, and the ΔRDW₄₋₁ differed significantly between survivors and non-survivors. Multivariate Cox regression analysis showed that the significance of the relationship between ΔRDW₄₋₁ and 30-day mortality risk remained after adjusting for age, PSI score, RDW at day 1, total protein concentration, and initial albumin level. CONCLUSION: RDW change from day 1 to day 4 was an independent predictor of mortality in patients with CAP.
Blood Urea Nitrogen ; Erythrocyte Indices ; Erythrocytes* ; Humans ; Medical Records ; Mortality ; Pneumonia* ; Retrospective Studies ; Survivors

Background: To identify sarcopenia as a predictive prognostic factor of ovarian cancer in terms of survival outcome in patients with early-stage ovarian cancer. Methods: Data of Konkuk University Medical Center from March 2002 to December 2017 were reviewed retrospectively. Eighty-two patients who underwent surgery due to early-stage (International Federation of Gynecology and Obstetrics stage I/II) ovarian cancer and had computed tomography (CT) images taken at the initial diagnosis were included. The initial CT scan images were analyzed with SliceOmatic software (TomoVision). A sarcopenia cutoff value was defined as a skeletal muscle index of ≤ 38.7 cm2 /m2 . Overall survival (OS) times were compared according to the existence of sarcopenia, and subgroup analyses were performed. Results: A Kaplan-Meier analysis showed a significant survival disadvantage for patients with early-stage ovarian cancer when they had sarcopenia (P < 0.001; log-rank test). Sarcopenia remained a significant prognostic factor for OS in early-stage ovarian cancer, in a Cox proportional hazards model regression analysis (HR, 21.9; 95% CI, 2.0–199.9; P = 0.006). Conclusion This study demonstrated that sarcopenia was predictive of OS in patients with early-stage ovarian cancer. Further prospective studies with a larger number of patients are warranted to determine the extent to which sarcopenia can be used as a prognostic factor in ovarian cancer.

OBJECTIVES: To evaluate the effects of 3-year hormone therapy, raloxifene and alendronate on lipid profile and body mass index (BMI) in Korean postmenopausal women. METHODS: We studied 107 postmenopausal women who had visited the Department of Obstetrics and Gynecology of Inje University Sanggye Paik Hospital between January 2000 and June 2010. These patients were divided into alendronate (n=21), raloxifene (n=18), estrogen therapy (ET) (n=35), estrogen-progesterone therapy (EPT) (n=33) group. Serum lipid profile was measured at baseline and 1, 2, 3-year after treatment. BMI were also assessed at baseline and 3-year after treatment. RESULTS: Total cholesterol level was decreased significantly after 3 years of treatment in EPT group by 5.0% and raloxifene group by 8.7%. Triglyceride level was decreased significantly after 3 years in alendronate group by 12%. HDL-cholesterol level was increased significantly after 2 years in ET group by 12% and EPT group by 6.0%. LDL-cholesterol level was decreased significantly after 1 year in ET group by 7.0% and EPT group by 13%. In raloxifene group, LDL-cholesterol level was decreased significantly after 3 years by 7%. BMI was not changed significantly after 3 years in all four groups. CONCLUSIONS: In postmenopausal women, the treatment with hormone therapy or raloxifene has a beneficial effect on lipid profiles. BMI was not changed.
Alendronate ; Body Mass Index ; Cholesterol ; Estrogens ; Female ; Gynecology ; Humans ; Obstetrics ; Raloxifene Hydrochloride